M&A Deal Summary

Abiomed Acquires Breethe

On April 29, 2020, Abiomed acquired medical products company Breethe

Acquisition Highlights
  • This is Abiomed’s 3rd transaction in the Medical Products sector.
  • This is Abiomed’s 1st transaction in Canada.
  • This is Abiomed’s 1st transaction in Quebec.

M&A Deal Summary
Date 2020-04-29
Target Breethe
Sector Medical Products
Buyer(s) Abiomed
Deal Type Add-on Acquisition

Target

Breethe

Longueuil, Quebec, Canada
Breethe, Inc. is a developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation, including patients suffering from cardiogenic shock or respiratory failures such as due to ARDS, H1N1, SARS, or COVID-19. ECMO has also been utilized as a primary method of oxygenation and hemodynamic support for pediatric patients. Breethe was founded in 2014 and is based in Longueuil, Quebec.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abiomed

Danvers, Massachusetts, United States
Category Company
Founded 1981
Sector Medical Products
Employees1,725
Revenue 1.0B USD (2022)
DESCRIPTION

Abiomed is a cardiovascular device company. Abiomed develops, manufactures, and markets medical products designed to establish recovery's as the standard of care for acute patients. Abiomed was formed in 1981 and is based in Danvers, Massachusetts.

DEAL STATS #
Overall 3 of 4
Sector (Medical Products) 3 of 4
Type (Add-on Acquisition) 3 of 4
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-01 ECP Entwicklungsgesellschaft mbH

Berlin, Germany

ECP Entwicklungsgesellschaft mbH is a medical device company. ECP is developing a product that is a percutaneous, expandable catheter pump which increases blood circulation from the heart with an external drive shaft.

Buy $13M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-01 preCARDIA

St. Paul, Minnesota, United States

preCARDIA provides patients’ quality of life through pioneering clinically advanced technology that offers an alternative solution for physicians and their patients suffering from ADHF. preCARDIA was founded in 2017 and is based in St. Paul, Minnesota.

Buy -
Mergr

Product

Company

Legal